The mechanisms by which microRNA dysfunction contributes to the pathogenesis of diffuse large B cell lymphoma (DLBCL) are not well established. The identification of the genes and pathways directly targeted by these small regulatory RNAs is a critical step to advance this field. Using unbiased genome-wide approaches in DLBCL, we discovered that the oncogenicmicroRNA- 155(miR-155) directly targets the bone morphogenetic protein (BMP)-responsive transcriptional factor SMAD5. Surprisingly, we found that in DLBCL a noncanonical signaling module linking TGF-β1 signals to SMAD5 is also active. In agreementwith these data,miR-155 overexpression renderedDLBCLs resistant tothegrowth-inhibitory effectsof both TGF-β1 andBMPs, via defective induction of p21 and impaired cell cycle arrest. In confirmatory experiments, RNAi-based SMAD5 knockdown recapitulated in vitro and in vivo the effects miR-155 overexpression. Furthermore, in primaryDLBCLs,miR-155 overexpression inhibited SMAD5expression and disrupted its activity, as defined by individual and global analyses of its transcriptional targets. Together, our data helped explain miR-155 function, highlighted a hitherto unappreciated role of SMAD5 in lymphoma biology, and defined a unique mechanism used by cancer cells to escape TGF-β's growth-inhibitory effects.
|Idioma original||English (US)|
|Número de páginas||6|
|Publicación||Proceedings of the National Academy of Sciences of the United States of America|
|Estado||Published - feb 16 2010|
ASJC Scopus subject areas